Department of Gastroenterology & Hepatology, Indiana University/Clarian Health Partner, Indianapolis, IN, USA.
J Pediatr Gastroenterol Nutr. 2010 Dec;51(6):718-22. doi: 10.1097/MPG.0b013e3181dac094.
Endoscopic ultrasound (EUS) with or without fine needle aspiration (FNA) has a well-established role in the evaluation of various gastrointestinal (GI) tract disorders in adults. The clinical impact of EUS on the management of the pediatric population remains less clear. This study evaluates the feasibility, safety, and applications of EUS ± FNA in pediatric GI tract disorders.
Using a prospectively maintained EUS database, all patients 18 years of age or younger referred for EUS at our institution were identified. Retrospective chart review was conducted to document procedure indications, type of anesthesia used, EUS findings, final FNA cytology results, and clinical impact of EUS ± FNA on the subsequent management of pediatric patients.
Fifty-eight EUS procedures were performed in 56 patients (35 girls). Median age was 16 years (range 4-18 years). The main indications for EUS were acute or recurrent pancreatitis, abdominal pain of suspected pancreatobiliary origin, suspected biliary obstruction, upper GI mucosal/submucosal lesions, and evaluation of pancreatic abnormalities seen on prior imaging. Sedation used included nurse-administered propofol sedation in 38 (73%), general anesthesia in 9 (17%), and fentanyl with meperidine in 3 (6%). Five therapeutic procedures performed included celiac plexus blocks in 4 and 1 EUS-guided pancreatogram. In 44 (86%) patients, EUS provided a new diagnosis. The procedure was successfully completed in all patients with no reported complications.
EUS ± FNA is feasible and safe and makes a significant impact on most pediatric patients. Nurse-administered propofol sedation appears to be safe and well tolerated in this group.
内镜超声(EUS)联合或不联合细针抽吸(FNA)在评估成人各种胃肠道(GI)疾病方面具有明确的作用。EUS 对儿科人群管理的临床影响尚不清楚。本研究评估了 EUS±FNA 在儿科 GI 疾病中的可行性、安全性和应用。
使用前瞻性维护的 EUS 数据库,确定我院收治的所有 18 岁或以下的 EUS 患者。通过回顾性病历审查,记录了检查适应证、使用的麻醉类型、EUS 结果、最终 FNA 细胞学结果,以及 EUS±FNA 对儿科患者后续管理的临床影响。
56 例患者(35 例女性)共进行了 58 次 EUS 检查。中位年龄为 16 岁(范围 4-18 岁)。EUS 的主要适应证为急性或复发性胰腺炎、疑似胰胆来源腹痛、疑似胆道梗阻、上消化道黏膜/黏膜下病变,以及先前影像学检查发现的胰腺异常。镇静包括 38 例(73%)患者使用护士管理的异丙酚镇静、9 例(17%)患者使用全身麻醉、3 例(6%)患者使用芬太尼联合哌替啶。共进行了 5 项治疗性操作,包括 4 例和 1 例腹腔神经丛阻滞的 EUS 引导下胰管造影。44 例(86%)患者的 EUS 提供了新的诊断。所有患者均成功完成了检查,无并发症报告。
EUS±FNA 是可行且安全的,对大多数儿科患者有重要影响。在该组患者中,护士管理的异丙酚镇静似乎是安全且耐受良好的。